Daily Archives: October 4, 2010

Public Meeting on Biosimilars Scheduled for November – Questions Posed by FDA

The FDA has finally scheduled a public meeting to solicit input on the regulatory pathway that is being developed for the approval of biosimilars.  The meeting is set for November 2-3 and will be held at FDA's facility in Silver … Continue reading

Posted in Biologics | Comments Off